Q32 Bio (QTTB) EBT Margin Growth (1y) (2019 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 609,119.00 |
| Sep 30, 2023 | 318,801.00 |
| Jun 30, 2023 | 328,926.00 |
| Mar 31, 2023 | -1.19 Mn |
| Dec 31, 2022 | 6,783.00 |
| Sep 30, 2022 | -211,411.00 |
| Jun 30, 2022 | -207,584.00 |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | -114,751.00 |
| Sep 30, 2021 | 315,402.00 |
| Jun 30, 2021 | 483,820.00 |
| Mar 31, 2021 | 600,501.00 |
| Dec 31, 2020 | 125,264.00 |
| Sep 30, 2020 | 173,895.00 |
| Jun 30, 2020 | 46,873.00 |
| Mar 31, 2020 | 282,540.00 |
| Dec 31, 2019 | -272,180.00 |
| Sep 30, 2019 | -583,499.00 |
| Jun 30, 2019 | -581,078.00 |
| Mar 31, 2019 | -792,911.00 |